orthospinenews

About orthospinenews

This author has not yet filled in any details.
So far orthospinenews has created 464 blog entries.

VISEON, Inc. Announces FDA Clearance of the Voyant System for Minimally Invasive Spine Surgery Access, Visualization, and Illumination

October 18, 2018 IRVINE, Calif.--(BUSINESS WIRE)--Viseon, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their Voyant System for Minimally Invasive Spine Surgery, featuring proprietary HD imaging sensor and illumination technology. The Voyant System is composed of a sterile single-use, disposable retractor device with integrated state-of-the-art

By |2018-10-18T18:16:18+00:00October 18th, 2018|Regulatory|

Kuros Biosciences Advances its Fibrin-PTH (KUR-113) Spinal Fusion Product Candidate Program

SCHLIEREN (ZURICH), Switzerland, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (SIX: KURN) announced today that the Company has reached a key milestone in its Fibrin-PTH (KUR-113) spinal fusion product candidate development program with the submission of a 510(k) regulatory package for its enabling lumbar intervertebral body fusion device to the U.S. Food and Drug

By |2018-10-18T17:16:52+00:00October 18th, 2018|Biologics|

Simplify Medical Appoints IP Attorney Veteran to VP, General Counsel

SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, today announced that it has appointed Cindy Lynch to Vice President, General Counsel. Ms. Lynch has nearly 15 years of experience providing strategic legal and intellectual property advice to medical device startups. Ms. Lynch’s appointment comes

By |2018-10-18T16:54:00+00:00October 18th, 2018|Spine|

TransEnterix CEO, Todd Pope Named One of TIME Magazine’s 50 Most Influential People in Health Care 2018

October 18, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M. Pope, for being named to TIME Magazine's 50 Most Influential People in Health Care for 2018. In this inaugural list,

By |2018-10-18T16:00:55+00:00October 18th, 2018|Robotics, Top Stories|

Amplitude Surgical – 2017-18 Annual Results: Sales of over €100 Million, up +8% Like-for-Like, and Solid EBITDA Growth of +17%

October 17, 2018 VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, announces its 2017-18 annual results. Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “Our strong growth, with annual sales exceeding €100 million, and the improvement

By |2018-10-18T15:46:43+00:00October 18th, 2018|Financial|

SI-BONE Announces Pricing of Initial Public Offering

SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN) ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the pricing of its initial public offering of 7,200,000 shares of common stock at a price to the public of $15.00 per share. In addition, SI-BONE has granted

By |2018-10-17T21:13:21+00:00October 17th, 2018|Financial|

Two new studies demonstrate INTERTAN™ Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures

LONDON, Oct. 17, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA two new studies showing positive clinical results and cost savings through using its INTERTAN Intertrochanteric Antegrade Nail. Patients recovering from a hip fracture often deal with various complications, including decline in

By |2018-10-17T20:48:34+00:00October 17th, 2018|Recon|

Pedicle Screw System Market – Global Forecast to 2023: Rising Geriatric Population, Technological Advancements & Growing Preference for Minimally Invasive Surgeries

DUBLIN, Oct. 17, 2018 /PRNewswire/ -- The "Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open, Minimal Invasive), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018,

By |2018-10-17T19:01:40+00:00October 17th, 2018|Financial|

Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis

Gosselies, Belgium, 17 October 2018, 6 pm CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces results of the first efficacy study of the Company’s enhanced viscosupplement, JTA-004, in patients with moderate symptomatic knee osteoarthritis, supporting future clinical development

By |2018-10-17T18:23:23+00:00October 17th, 2018|Biologics|

SPINEWAY : Marketing of new Mont-Blanc Evo product line authorized in the United States

Ecully, October 17 2018 Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), completed all the regulatory steps and can market its Mont-Blanc Evo product line (presented at the Eurospine conference) in the United States. This development of the flagship Mont-Blanc line that is already distributed on territory provides

By |2018-10-17T17:45:44+00:00October 17th, 2018|Spine|